AH
Therapeutic Areas
Disco Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Discovery Program | Small Cell Lung Cancer | Discovery |
Leadership Team at Disco Pharmaceuticals
MM
Mark Manfredi, PhD
Chief Executive Officer
JH
Johannes Heuckmann, PhD
Co-Founder & Chief Operating Officer